By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Acasti Pharma 

225 Promenade du Centropolis
Suite 200
Laval  Quebec  H7T 3B3  Canada
Phone: 450-687-2262 Fax: 450-687-2272




Company News
Acasti Pharma Granted Additional Composition & Use Patents In Taiwan And Australia; Safeguards Valuable Market Expansion Opportunities 4/24/2017 11:56:34 AM
Acasti Pharma Provides Update On CaPre Phase III Development Program 3/30/2017 11:38:40 AM
Acasti Pharma Forms Scientific Advisory Board And Appoints Two Leading Cardiovascular Disease Experts 3/8/2017 11:03:36 AM
Acasti Pharma Announces Closings Of Concurrent Public Offering Of Units And Private Placement Of Convertible Debentures And Warrants 2/22/2017 7:44:40 AM
Acasti Pharma Reports Positive CaPre Omega-3 Bridging Study Data 9/15/2016 12:09:31 PM
Acasti Pharma Names a New CEO 5/12/2016 7:17:19 AM
Acasti Pharma Announces Share-for-Debt 2/8/2016 11:52:26 AM
Acasti Pharma Granted Composition & Use Patent In Japan, Taiwan And Mexico 12/1/2015 7:51:44 AM
Acasti Pharma Announces 1-for-10 Reverse Stock Split 9/29/2015 6:56:36 AM
Acasti Pharma Announces Grant Of Stock Options 8/20/2015 8:09:14 AM